Mechanism of Effects of Emodin on Gastric Dynamics in Type 2 Diabetic Rats

李艳芬,严祥,赵丽,陈明,张新华
2008-01-01
Abstract:OBJECTIVE: To investigate the mechanism of the effects of Emodin on the gastric motility of type 2 diabetic rats. METHODS: Murine type 2 diabetes model was induced in rats by intravenous injection of a small dose of streptozotocin plus long-term high fat high caloric laboratory chow. Then the model rats were treated with Emodin(EMO), tegaserod (TEG) or domperidone(DOM) for 6 weeks, with control(NOR) and model(MOD) groups as comparison. Gastric emptying half time(GET1/2) and 90 min residual rate(RIH) were measured by single photon emission computed tomography(SPECT) be-fore sacrifice. The fasting blood glucose and serum insulin, riglycerides TG), total cholesterol(TC),high density lipoprotein-cholesterol(HDL-C) were determined by biochemical methods. Plasma and tissue levels of substance P(SP) and somatostatin(SS) were determined using radioimmunoassay. RESULTS: Gastric emptying in model group was significantly slower than in normal control group(P0.01), but were significantly sped up after treatment by Emodin, tegaserod or domperidone(P0.01 or P0.05). Plasma and intestine levels of SP were significantly increased while SS were significantly decreased after treatment by emodin, tegaserod or domperidone as compared with model group(P0.01 or P0.05). Serum TG and TC were significantly higher while HDL-C was lower in the model group and tegaserod or domperidone-treated group than those in normal group(P0.01), but serum TG, TC and HDL-C levels were regulated to normal in Emodin-treated group(P0.01). CONCLUSION: Emodin can promote the gastrointestinal motility in type 2 diabetic rats is possibly related to its ability to regulate the abnormal expression of gastrointestinal hormones.
What problem does this paper attempt to address?